News and publications

New joint EPO-EUIPO study on startup finance reveals how IP helps startups raise finance

European startups applying for patents and/or trademarks during their initial seed or early growth stages are up to 10.2 times more likely to secure funding from investors. What’s more, the ownership of European patents and EU trademarks is associated with an even higher advantage, with a rate of securing early-stage funding exceeding five times that of those with only national intellectual property rights. These are the key findings of a new study published jointly by the EPO and EUIPO.
The key findings of the study include:

• On average, 29% of European startups have filed for patents or registered trademarks, though there are significant differences between industry sectors.
• Startups increasingly make use of IP rights as they grow, with a strong focus on European IP rights at all growth stages.
• The filing of patent and trademark applications in the seed or early growth stage is associated with a higher likelihood of subsequent venture capital (VC) funding.
• The filing of applications for European patent and EU trademark is associated with an even higher likelihood of subsequent VC funding for startups (compared to just national IP rights).
• The filing of patent and/or trademark applications is associated with a more than twice as high likelihood of successful exit for investors.

pat

Recent Posts

Tracking deadlines is an essential aspect of patent prosecution

Dear colleagues, we would like to inform you about the weekends and holidays in 2025…

1 неделя ago

October 24-26, 2024 | Patentica took part in AIPLA 2024 Annual Meeting

Maria Nilova and Nikolai Kovkov from Patentica recently participated in the AIPLA 2024 Annual Meeting…

4 недели ago

Patentica participated in the LES USA-Canada Annual Meeting | October 20-23, 2024

Maria Nilova and Nikolai Kovkov from Patentica recently took part in the LES USA-Canada Annual…

1 месяц ago

4,667 intellectual property infringements were identified in the EAEU in 2023

On October 9, a meeting of the Advisory Committee on Intellectual Property under the Board…

1 месяц ago

Rospatent’s clarifications on the Statute on Fees as amended

The Russian Patent and Trademark Office has issued clarifications regarding some typical questions on the…

2 месяца ago

Revocation of Patent RU 2421238 Related to Liraglutide Composition (Sun Pharmaceuticals Industries, Ltd (IN) v. Novo Nordisk A/S (DK))

Patentica’s patent attorneys, Victor Lisovenko and Ksenia Emelianova have successfully represented Sun Pharmaceuticals in opposing…

2 месяца ago